Background In Lithuania, the first case of canine subcutaneous dirofilariosis was recorded in 2010. Since then, an increasing number of cases of canine dirofilariosis have been documented in different veterinary clinics throughout the country. Human dirofilariosis was diagnosed in Lithuania for the first time in September 2011. However, to the authors’ knowledge, there are no published data on the presence and prevalence of autochthonous dirofilariosis in dogs and humans in the country. The present study provides information about the predominant species and prevalence of Dirofilaria in dogs and describes the cases of human dirofilariosis in Lithuania. It also outlines PCR detection of the bacterial endosymbiont Wolbachia that contributes to the inflammatory features of filarioid infection. Results A total of 2280 blood samples and six adult worms from pet and shelter dogs were collected in the central and eastern regions of Lithuania in 2013–2015. Based on their morphological appearance, morphometric measurements and molecular analysis, all the adult nematodes were identified as Dirofilaria repens. The diagnosis of microfilariae in blood samples was based on blood smear analysis and Knott’s test. The PCR and sequence analysis of the ribosomal DNA ITS2 region and cox 1 gene confirmed the presence of D. repens . Overall, 61 (2.7%) of the 2280 blood samples were found to be positive for the presence of D. repens. The infection rate of D. repens was significantly higher in shelter dogs (19.0%; 19/100) than in pet dogs (1.9%; 42/2180) ( χ 2 = 100.039, df = 1, P < 0.0001). Forty-nine DNA samples of D. repens -infected dogs were tested for the presence of the bacterial endosymbiont Wolbachia and, of these, 40 samples (81.6%) were found to be positive. Three ocular and six subcutaneous cases of human dirofilariosis were diagnosed in Lithuania in the period 2011–2018. Conclusions To the authors’ knowledge, this is the first report of autochthonous D. repens infection in dogs and humans in Lithuania. The present data demonstrate that D. repens is the main etiological agent of dirofilariosis in Lithuania. The DNA of the filarioid endosymbiotic bacterium Wolbachia was detected in the vast majority of dogs infected with D. repens .
SummaryOver the past decade, increasing numbers of autochthonous cases of heartworm infection have been reported in the countries of Eastern Europe where previously only imported cases were described. In this report we have described the first clinical case of Dirofilaria immitis infection in an imported dog in Lithuania.In 2018, a 5-year-old male Spanish greyhound (Spanish galgo) was imported to Lithuania from southern Spain and referred to a small animal veterinary clinic in Vilnius for wellness screening. Circulating microfilariae and female antigens of D. immitis were detected using the Knott’s test and SNAP 4Dx Plus Test (IDEXX Laboratories, Portland, USA). The diagnosis was confirmed using molecular analysis. Treatment according to the guidelines recommended by the American Heartworm Society was applied. This is the first confirmed report of canine heartworm infection in an imported dog in Lithuania. Heartworm-infected dogs transported to North-Eastern Europe from endemic areas could act as microfilarial reservoirs for the local mosquito population, which could increase the risk of spreading the disease.
The aim of this study was to screen free-ranging red foxes from Lithuania for the presence of different vector-borne pathogens. A total of 31 red foxes from three districts of Lithuania were molecularly tested for the presence of pathogens. Five different pathogens were detected in 83.9% of red foxes: Anaplasma spp., Bartonella spp., Rickettsia spp., Borrellia spp. and Babesia spp. The presence of Mycoplasma spp. and Dirofilaria spp. was not detected in our study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.